Privacy Statement

Allergan respects your privacy and recognizes your need for appropriate protection and management of personally identifiable information you share with us (the phrases “personally identifiable information” means any information by which you can be identified, such as your name, address, telephone number, etc.). The purpose of this privacy statement is to inform you what personally identifiable information we may collect from you when you visit our Site, and how we use such information, and the choices you have regarding our use of, and your ability to review and correct, the information. As we may revise our privacy policies from time to time, you should therefore periodically visit this page to review the then current Privacy Statement.

How we collect information

In general, you can visit many of our Web pages without telling us who you are or revealing any personally identifiable information. We may track the Internet domain address from which people visit us and analyze this data for trends and statistics, but individual users will remain anonymous, unless you voluntarily tell us who you are.

There may be times at which we ask you to provide certain information about yourself, such as your name, address, telephone number, e-mail address, etc. Whether or not to provide such information is completely your own choice; Allergan collects only the personal information that you provide to us. But if you choose not to provide the information we request, you may be unable to access certain services, offers, and content on our Site.

Cookies

To enable Allergan to provide customized and personalized services, Allergan may use cookies to store and sometimes track information about you. A cookie is a small amount of data that is sent to your browser from a Web server and stored on your computer. Cookies, by themselves, do not tell us any personally identifiable information about you. However, if you choose to furnish the Site with personally identifiable information (such as your e-mail address), that information could be linked to the data stored in the cookie. Allergan reserves the right to change our use of cookies and our practices regarding linkage to personally identifiable information without any prior notification.

How we use the information we collect

We use the information we automatically receive from your Web browser to see which pages you visit within our Site. We can then develop statistics that are helpful to understanding how this Site is used by our visitors. This statistical data is interpreted by Allergan in its continuing effort to present the Site content that visitors are seeking in a format they find most helpful.

When Allergan receives personally identifiable information, we may use it for reasonable business purposes, such as contacting you, via e-mail or regular mail, to provide you with information we believe may be of interest. If you e-mail us, you are voluntarily releasing information to us. Your e-mail address will be used by Allergan to respond to you.

Third-party use of information

Allergan will not sell, share, or otherwise distribute your personally identifiable information to third parties except as provided herein. However, personally identifiable information may occasionally be transferred to third parties who act for or on behalf of Allergan, or in connection with the business of Allergan, for further processing in accordance with the purposes for which the data was originally collected. Where disclosure of personally identifiable information to a third party is likely or necessary, further explanation may be provided, where appropriate, at such collection points as to the intended use of the data. We require that such third parties protect the information and, where appropriate, we will contractually require them to process data transferred only for the purposes expressly authorized by Allergan.

Because of the nature of the Internet, we may transmit the information to another country, but within Allergan, for purposes other than direct marketing, such as for storage, or because of where our servers are located. We may also use it to investigate security breaches or cooperate with authorities pursuant to a legal matter. We may also remove all the personally identifiable information and use the rest for historical, statistical, or scientific purposes. This Site contains links to other sites. Be aware that Allergan is not responsible for the privacy practices of non-Allergan sites. We encourage you to review the privacy statements of any Web sites that you visit through a link on this Site.

Questions and comments

If you have any questions or comments about Allergan’s Privacy Policy or if you wish to review and correct your personally identifiable information held by Allergan, please contact us by clicking on the Contact Us link within the Site and by inserting the words “Privacy Policy” in the Subject line.


 
BOTOX® is indicated for the treatment of cervical dystonia in adults to decrease the severity of abnormal head position and neck pain associated with cervical dystonia.

IMPORTANT SAFETY INFORMATION

Contraindications
BOTOX® treatment is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any ingredient in the formulation.

Warnings
The recommended dosage and frequency of administration for BOTOX® should not be exceeded. Risks resulting from administration at higher dosages are not known.

Serious and/or immediate hypersensitivity reactions have been rarely reported. These reactions include anaphylaxis, urticaria, soft-tissue edema, and dyspnea. Patients with peripheral motor neuropathic diseases (eg, amyotrophic lateral sclerosis or motor neuropathy) or neuromuscular junctional disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should only receive BOTOX® treatment with caution. Patients with neuromuscular disorders may be at increased risk of clinically significant systemic effects including severe dysphagia and respiratory compromise from typical BOTOX® doses.

Adverse events
There have been rare spontaneous reports of death, sometimes associated with dysphagia, pneumonia, and/or other significant debility or anaphylaxis, after treatment with botulinum toxin. There have been rare reports of adverse events involving the cardiovascular system. The most frequently reported adverse reactions in patients with cervical dystonia following BOTOX® injection are dysphagia (19%), upper respiratory infection (12%), neck pain (11%), and headache (11%).

Please see full prescribing information

© 2007 ALLERGAN / Terms of Use / Privacy / Contact Us

® and ™ marks owned by Allergan, Inc.

The information on this site is intended for US residents only.
No information in this site is provided with the intention to give medical advice or instructions on the accurate use of Allergan products. Allergan cannot answer unsolicited e-mails requesting personal medical advice; visitors should always consult a healthcare professional.